Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-01-04 13:53:42
Reporting Period:
Filing Date:
Accepted Time:
2012-01-04 13:53:42
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1339455 Somaxon Pharmaceuticals Inc. SOMX Pharmaceutical Preparations (2834) 200161599
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380762 Brian Dorsey Somaxon Pharmaceuticals, Inc.
10935 Vista Sorrento Pkwy. Ste 250
San Diego CA 92130
Svp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-03 9,000 $0.48 134,452 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person with the proceeds remitted to the Company to cover the taxes withheld upon the vesting of 10,000 restricted stock units on December 31, 2011 and 10,000 restricted stock units on January 1, 2012.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4501 to $0.498, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.